Evidence map›Paper›PMID 41131735›Full record

ArticleBritish journal of haematology2026

Current management of non-amyloidosis monoclonal gammopathy of renal significance: Clinical features, treatment selections, responses and renal outcomes.

Daniel Cancilla, Hanny Sawaf, Xuefei Jia, Danai Dima, Ali Mehdi, Hira Shaikh, Beth Faiman, Faiz Anwer, Sandra Mazzoni, Diana Basali and 5 more

Abstract read
In one paragraph

Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Two Heads Are Better Than One: Second Opinions and Collaborations in Oncology.Journal of the advanced practitioner in oncology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Daniel CancillaCleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA.ORCID https://orcid.org/0009-0009-0711-7205
Hanny SawafCleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA.
Xuefei JiaCleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA.
Danai DimaCleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA.
Ali MehdiCleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA.
Hira ShaikhHolden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa, USA.
Beth FaimanCleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA.
Faiz AnwerCleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA.
Sandra MazzoniCleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA.
Diana BasaliCleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA.ORCID https://orcid.org/0000-0001-6984-9684
Jack KhouriCleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA.
Christy SamarasCleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA.
Jason ValentCleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA.
Shahzad RazaCleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA.
Louis WilliamsCleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

monoclonal gammopathy of renal significance (MGRS)paraprotein‐related kidney diseaseproliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID)

Identifiers

PMID41131735
PMCPMC12819080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.